Sebaceous neoplasia and Torre-Muir syndrome

Current Diagnostic Pathology

Volumn 13, Issue 4, 2007, Pages 301-319

  Lazar, A J F ^a   Lyle, S ^b   Calonje, E ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Microsatellite instability; Sebaceoma; Sebaceous adenoma; Sebaceous carcinoma; Sebaceous hyperplasia; Sebaceous neoplasia; Torre Muir syndrome

Indexed keywords

REAGENT;

ADENOMA; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CARCINOGENESIS; CARCINOMA; COLORECTAL CARCINOMA; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; EPITHELIUM TUMOR; EYE; GENETIC DISORDER; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTESTINE CANCER; MUIR TORRE SYNDROME; NONHUMAN; PATHOLOGICAL ANATOMY; SEBACEOMA; SEBACEOUS TUMOR; SKIN CANCER; TUBEROUS SCLEROSIS; TUMOR;

EID: 34548040434     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2007.05.001     Document Type: Article

References (96)

1. Porter A.M. Why do we have apocrine and sebaceous glands?. J R Soc Med 94 (2001) 236-237
2. Danby F.W. Why we have sebaceous glands. J Am Acad Dermatol 52 (2005) 1071-1072
3. Kumar P., and Marks R. Sebaceous gland hyperplasia and senile comedones: a prevalence study in elderly hospitalized patients. Br J Dermatol 117 (1987) 231-236
4. Davis T.T., Calilao G., and Fretzin D. Sebaceous hyperplasia overlying a dermatofibroma. Am J Dermatopathol 28 (2006) 155-157
5. Requena L., Roo E., and Sanchez Yus E. Plate-like sebaceous hyperplasia overlying dermatofibroma. J Cutan Pathol 19 (1992) 253-255
6. Zaballos P., Ara M., Puig S., and Malvehy J. Dermoscopy of sebaceous hyperplasia. Arch Dermatol 141 (2005) 808
7. Salim A., Reece S.M., Smith A.G., et al. Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant. J Am Acad Dermatol 55 (2006) 878-881
8. Pang S.M., and Chau Y.P. Cyclosporin-induced sebaceous hyperplasia in renal transplant patients. Ann Acad Med Singapore 34 (2005) 391-393
9. Bencini P.L., Montagnino G., Sala F., De Vecchi A., Crosti C., and Tarantino A. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dermatologica 172 (1986) 24-30
10. Kim Y.S., Jin S.Y., and Shim C.S. Esophageal ectopic sebaceous glands. Clin Gastroenterol Hepatol 5 (2007) A23
11. De La Pava S., and Pickren J.W. Ectopic sebaceous glands in the esophagus. Arch Pathol 73 (1962) 397-399
12. Rulon D.B., and Helwig E.B. Cutaneous sebaceous neoplasms. Cancer 33 (1974) 82-102
13. Prioleau P.G., and Santa Cruz D.J. Sebaceous gland neoplasia. J Cutan Pathol 11 (1984) 396-414
14. Epker B.N., and Henny F.A. Intra-oral sebaceous gland adenoma. Cancer 27 (1971) 987-1000
15. Orlian A.I., Salman L., Reddi T., Yamane G.M., and Chaudhry A.P. Sebaceous adenoma of the oral mucosa. J Oral Med 42 (1987) 38-39
16. Troy J.L., and Ackerman A.B. Sebaceoma. A distinctive benign neoplasm of adnexal epithelium differentiating toward sebaceous cells. Am J Dermatopathol 6 (1984) 7-13
17. Misago N., Mihara I., Ansai S., and Narisawa Y. Sebaceoma and related neoplasms with sebaceous differentiation: a clinicopathologic study of 30 cases. Am J Dermatopathol 24 (2002) 294-304
18. Kazakov D.V., Kutzner H., Rutten A., Mukensnabl P., and Michal M. Carcinoid-like pattern in sebaceous neoplasms: another distinctive, previously unrecognized pattern in extra-ocular sebaceous carcinoma and sebaceoma. Am J Dermatopathol 27 (2005) 195-203
19. Misago N., and Narisawa Y. Rippled-pattern sebaceoma. Am J Dermatopathol 23 (2001) 437-443
20. Kiyohara T., Kumakiri M., Kuwahara H., Saitoh A., and Ansai S. Rippled-pattern sebaceoma: a report of a lesion on the back with a review of the literature. Am J Dermatopathol 28 (2006) 446-448
21. Misago N., Suse T., Uemura T., and Narisawa Y. Basal cell carcinoma with sebaceous differentiation. Am J Dermatopathol 26 (2004) 298-303
22. Dinneen A.M., and Mehregan D.R. Sebaceous epithelioma: a review of twenty-one cases. J Am Acad Dermatol 34 (1996) 47-50
23. Shields J.A., Demirci H., Marr B.P., Eagle Jr. R.C., and Shields C.L. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 111 (2004) 2151-2157
24. Callahan E.F., Appert D.L., Roenigk R.K., and Bartley G.B. Sebaceous carcinoma of the eyelid: a review of 14 cases. Dermatol Surg 30 (2004) 1164-1168
25. Rao N.A., Hidayat A.A., McLean I.W., and Zimmerman L.E. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol 13 (1982) 113-122
26. Doxanas M.T., and Green W.R. Sebaceous gland carcinoma. Review of 40 cases. Arch Ophthalmol 102 (1984) 245-249
27. Muqit M.M., Roberts F., Lee W.R., and Kemp E. Improved survival rates in sebaceous carcinoma of the eyelid. Eye 18 (2004) 49-53
28. Marback E.F., Costa A.L., Nossa L.M., Marback R.L., and Rao N.A. Eyelid skin adenoid cystic carcinoma: a clinicopathological study of one case simulating sebaceous gland carcinoma. Br J Ophthalmol 87 (2003) 118-119
29. Singh A.D., Mudhar H.S., Bhola R., Rundle P.A., and Rennie I.G. Sebaceous adenoma of the eyelid in Muir-Torre syndrome. Arch Ophthalmol 123 (2005) 562-565
30. Wick M.R., Goellner J.R., Wolfe III J.T., and Su W.P. Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas. Cancer 56 (1985) 1163-1172
31. Moreno C., Jacyk W.K., Judd M.J., and Requena L. Highly aggressive extraocular sebaceous carcinoma. Am J Dermatopathol 23 (2001) 450-455
32. Reina R.S., and Parry E. Aggressive extraocular sebaceous carcinoma in a 52-year-old man. Dermatol Surg 32 (2006) 1283-1286
33. Matsuda K., Doi T., Kosaka H., et al. Sebaceous carcinoma arising in naevus sebaceus. J Dermatol 32 (2005) 641-644
34. Miller C.J., Ioffreda M.D., and Billingsley E.M. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a naevus sebaceus. Dermatol Surg 30 (2004) 1546-1549
35. Alessi E., Wong S.N., Advani H.H., and Ackerman A.B. Naevus sebaceus is associated with unusual neoplasms. An atlas. Am J Dermatopathol 10 (1988) 116-127
36. Friedman K.J., Boudreau S., and Farmer E.R. Superficial epithelioma with sebaceous differentiation. J Cutaneous Pathol 14 (1987) 193-197
37. Rothko K., Farmer E.R., and Zeligman I. Superficial epithelioma with sebaceous differentiation. Arch Dermatol 116 (1980) 329-331
38. Steffen C. Mantleoma. A benign neoplasm with mantle differentiation. Am J Dermatopathol 15 (1993) 306-310
39. Wolins N.E., Quaynor B.K., Skinner J.R., et al. S3-12, adipophilin, and TIP47 package lipid in adipocytes. J Biol Chem 280 (2005) 19146-19155
40. Robenek H., Robenek M.J., and Troyer D. PAT family proteins pervade lipid droplet cores. J Lipid Res 46 (2005) 1331-1338
41. Muthusamy K., Halbert G., and Roberts F. Immunohistochemical staining for adipophilin, perilipin and TIP47. J Clin Pathol 59 (2006) 1166-1170
42. Bayer-Garner I.B., Givens V., and Smoller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol 21 (1999) 426-431
43. Johnson J.S., Lee J.A., Cotton D.W., Lee W.R., and Parsons M.A. Dimorphic immunohistochemical staining in ocular sebaceous neoplasms: a useful diagnostic aid. Eye 13 (1999) 104-108
44. Ansai S., Hashimoto H., Aoki T., Hozumi Y., and Aso K. A histochemical and immunohistochemical study of extra-ocular sebaceous carcinoma. Histopathology 22 (1993) 127-133
45. Fan YS, Carr RA, Sanders DSA, Smith AP, Lazar AJF, Calonje E. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Histopathol, 2007, in press.
46. Torre D. Multiple sebaceous tumours. Arch Dermatol 98 (1968) 549-551
47. Muir E.G., Bell A.J., and Barlow K.A. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg 54 (1967) 191-195
48. Schwartz R.A., and Torre D.P. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 33 (1995) 90-104
49. Lynch H.T., Fusaro R.M., and Lynch P.M. Sebaceous skin lesions as clues to hereditary non-polyposis colorectal cancer. J Invest Dermatol 126 (2006) 2158-2159
50. Tsalis K., Blouhos K., Vasiliadis K., et al. Sebaceous gland tumours and internal malignancy in the context of Muir-Torre syndrome. A case report and review of the literature. World J Surg Oncol 4 (2006) 8
51. Abbott J.J., Hernandez-Rios P., Amirkhan R.H., and Hoang M.P. Cystic sebaceous neoplasms in Muir-Torre syndrome. Arch Pathol Lab Med 127 (2003) 614-617
52. Misago N., and Narisawa Y. Sebaceous neoplasms in Muir-Torre syndrome. Am J Dermatopathol 22 (2000) 155-161
53. Burgdorf W.H., Pitha J., and Fahmy A. Muir-Torre syndrome. Histologic spectrum of sebaceous proliferations. Am J Dermatopathol 8 (1986) 202-208
54. Cohen P.R. Sebaceous carcinomas of the ocular adnexa and the Muir-Torre syndrome. J Am Acad Dermatol 27 (1992) 279-280
55. Rutten A., Burgdorf W., Hugel H., et al. Cystic sebaceous tumours as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study. Am J Dermatopathol 21 (1999) 405-413
56. Halling K.C., Honchel R., Pittelkow M.R., and Thibodeau S.N. Microsatellite instability in keratoacanthoma. Cancer 76 (1995) 1765-1771
57. Ponti G., Ponz de Leon M., Losi L., et al. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families. Br J Dermatol 152 (2005) 1335-1338
58. Rothenberg J., Lambert W.C., Vail Jr. J.T., Nemlick A.S., and Schwartz R.A. The Muir-Torre (Torre's) syndrome: the significance of a solitary sebaceous tumour. J Am Acad Dermatol 23 (1990) 638-640
59. Donati P. Solitary sebaceoma in Muir-Torre syndrome. Int J Dermatol 35 (1996) 601-602
60. Mangold E., Pagenstecher C., Leister M., et al. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet 41 (2004) 567-572
61. Barana D., van der Klift H., Wijnen J., et al. Spectrum of genetic alterations in Muir-Torre syndrome is the same as in HNPCC. Am J Med Genet A 125 (2004) 318-319
62. Ponti G., Losi L., Pedroni M., et al. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumours or keratoacanthomas. J Invest Dermatol 126 (2006) 2302-2307
63. Ollila S., Fitzpatrick R., Sarantaus L., et al. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC. Int J Oncol 28 (2006) 149-153
64. Abdel-Rahman W.M., and Peltomaki P. Molecular basis and diagnostics of hereditary colorectal cancers. Ann Med 36 (2004) 379-388
65. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
66. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
67. Rodriguez-Bigas M.A., Boland C.R., Hamilton S.R., et al. A National Cancer Institute Workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89 (1997) 1758-1762
68. Peris K., Onorati M.T., Keller G., et al. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome. Br J Dermatol 137 (1997) 356-360
69. Kruse R., Rutten A., Hosseiny-Malayeri H.R., et al. 'Second hit' in sebaceous tumours from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation. J Invest Dermatol 116 (2001) 463-465
70. Marcus V.A., Madlensky L., Gryfe R., et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumours. Am J Surg Pathol 23 (1999) 1248-1255
71. Lindor N.M., Burgart L.J., Leontovich O., et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumours. J Clin Oncol 20 (2002) 1043-1048
72. Casey G., Lindor N.M., Papadopoulos N., et al. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. J Am Med Assoc 293 (2005) 799-809
73. Lazar A.J., Ribic C., Zubovits J., et al. Immunohistochemistry for deficiency of mismatch repair proteins MLH1, MSH2 and MSH6 identifies colorectal carcinoma with high-frequency microsatellite instability (USCAP Abstract). Mod Pathol 15 Suppl 1 (2002) 135A
74. Mathiak M., Rutten A., Mangold E., et al. Loss of DNA mismatch repair proteins in skin tumours from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol 26 (2002) 338-343
75. Liang S.B., Furihata M., Takeuchi T., Sonobe H., and Ohtsuki Y. Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma. Virchows Arch 439 (2001) 622-627
76. Popnikolov N.K., Gatalica Z., Colome-Grimmer M.I., and Sanchez R.L. Loss of mismatch repair proteins in sebaceous gland tumours. J Cutan Pathol 30 (2003) 178-184
77. Lazar A.J., Redston M., Grayson W., and Calonje E. Analysis of sebaceous hyperplasia, adenoma and carcinoma by immunohistochemistry for deficiency of DNA mismatch repair proteins MLH1, MSH2 and MSH6 (USCAP Abstract). Mod Pathol 17 Suppl 1 (2004) 94A
78. Ponti G., Losi L., Di Gregorio C., et al. Identification of Muir-Torre syndrome among patients with sebaceous tumours and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 103 (2005) 1018-1025
79. Papadopoulos N., and Lindblom A. Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 10 (1997) 89-99
80. Reitmair A.H., Redston M., Cai J.C., et al. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res 56 (1996) 3842-3849
81. Reitmair A.H., Schmits R., Ewel A., et al. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11 (1995) 64-70
82. Niemann C., Owens D.M., Hulsken J., Birchmeier W., and Watt F.M. Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours. Development 129 (2002) 95-109
83. Nguyen H., Rendl M., and Fuchs E. Tcf3 governs stem cell features and represses cell fate determination in skin. Cell 127 (2006) 171-183
84. Blanpain C., and Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 22 (2006) 339-373
85. Perez-Moreno M., and Fuchs E. Catenins: keeping cells from getting their signals crossed. Dev Cell 11 (2006) 601-612
86. Takeda H., Lyle S., Lazar A.J., et al. Human sebaceous tumours harbor inactivating mutations in LEF1. Nat Med 12 (2006) 395-397
87. Chan E.F., Gat U., McNiff J.M., and Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 21 (1999) 410-413
88. Lazar A.J., Calonje E., Grayson W., et al. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J Cutan Pathol 32 (2005) 148-157
89. Niemann C., Unden A.B., Lyle S., et al. Indian hedgehog and beta-catenin signaling: role in the sebaceous lineage of normal and neoplastic mammalian epidermis. Proc Natl Acad Sci USA 100 Suppl 1 (2003) 11873-11880
90. Watt F.M., Lo Celso C., and Silva-Vargas V. Epidermal stem cells: an update. Curr Opin Genet Dev 16 (2006) 518-524
91. Lyle S., Christofidou-Solomidou M., Liu Y., et al. Human hair follicle bulge cells are biochemically distinct and possess an epithelial stem cell phenotype. J Invest Dermatol Symp Proc 4 (1999) 296-301
92. Burkert J., Wright N.A., and Alison M.R. Stem cells and cancer: an intimate relationship. J Pathol 209 (2006) 287-297
93. Finlan L.E., and Hupp T.R. Epidermal stem cells and cancer stem cells: insights into cancer and potential therapeutic strategies. Eur J Cancer 42 (2006) 1283-1292
94. Li L., and Neaves W.B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66 (2006) 4553-4557
95. Misago N., and Narisawa Y. Cytokeratin 15 expression in neoplasms with sebaceous differentiation. J Cutan Pathol 33 (2006) 634-641
96. Bieniek R., Lazar A.J., Photopoulos C., and Lyle S. Sebaceous tumours contain a subpopulation of cells expressing the keratin 15 stem cell marker. Br J Dermatol 156 (2007) 378-380